Intraoperative coronary vein graft thrombosis: Should we blame the use of aprotinin?
Main Authors: | Sivasubramaniam S, Murali B, Smallpiece C, Smith BAC, Kalkat M |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
Series: | Annals of Cardiac Anaesthesia |
Online Access: | http://www.annals.in/article.asp?issn=0971-9784;year=2009;volume=12;issue=1;spage=84;epage=86;aulast=Sivasubramaniam |
Similar Items
-
Mortality in hydatidiform mole: Should we blame thyroid?
by: Ghanshyam Biyani, et al.
Published: (2011-01-01) -
Topical Use of Aprotinin in Coronary Artery Bypass Surgery
by: Jiří Manďák, et al.
Published: (1999-01-01) -
AntifibrinolyticAgents: Aprotinin, and Desmopressin
by: Pramila Bajaj
Published: (2009-01-01) -
APROTININ - An Update for the Perioperative Physician
by: Bojanov George, et al.
Published: (2005-01-01) -
Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery
by: Omid Aghadavoudi
Published: (2012-01-01)